URINARY BLADDER NEOPLASMS
Clinical trials for URINARY BLADDER NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new URINARY BLADDER NEOPLASMS trials appear
Sign up with your email to follow new studies for URINARY BLADDER NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New bladder cancer treatment tested after standard therapy fails
Disease control TerminatedThis study tested a drug called enfortumab vedotin for people with non-muscle invasive bladder cancer that didn't respond to standard BCG therapy. The drug was delivered directly into the bladder through a thin tube. The study aimed to find the right dose and see if it could help…
Matched conditions: URINARY BLADDER NEOPLASMS
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Apr 04, 2026 00:20 UTC
-
Immune-Boosting drug tested to fight recurring bladder cancer
Disease control TerminatedThis study aimed to see if adding an immunotherapy drug called nivolumab to the standard BCG treatment could better control high-risk bladder cancer that had come back or persisted after initial BCG therapy. It was a large Phase 3 trial that was terminated early, enrolling only 1…
Matched conditions: URINARY BLADDER NEOPLASMS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC